The derivation of a flavonol is crucial for its application in healthcare and the food industry. Here, we provide a detailed protocol for the biosynthesis of a flavonol from a flavanone and discuss the crucial steps and its advantages over other approaches.
Flavonols are a major subclass of flavonoids with a variety of biological and pharmacological activities. Here, we provide a method for the in vitro enzymatic synthesis of a flavonol. In this method, Atf3h and Atfls1, two key genes in the biosynthetic pathway of the flavonols, are cloned and overexpressed in Escherichia coli. The recombinant enzymes are purified via an affinity column and then a bienzymatic cascade is established in a specific synthetic buffer. Two flavonols are synthesized in this system as examples and determined by TLC and HPLC/LC/MS analyses. The method displays obvious advantages in the derivation of flavonols over other approaches. It is time- and labor-saving and highly cost-effective. The reaction is easy to be accurately controlled and thus scaled up for mass production. The target product can be purified easily due to the simple components in the system. However, this system is usually restricted to the production of a flavonol from a flavanone.
Flavonols are a major subclass of plant flavonoids and are involved in plant development and pigmentation1,2,3. More importantly, these compounds possess a wide range of health-beneficial activities, such as anti-cancer4,5, anti-oxidative6, anti-inflammatory7, antiobesity8, anti-hypertensive9, and memory recall properties10, leading to a large number of studies on these plant-derived secondary metabolites. Traditionally, these compounds are mainly derived from plant extraction using organic solvents. However, due to their very low contents in plants11,12,13, the production cost for most flavonols remains high, which imposes great restrictions on their application in healthcare and the food industry.
During the past decades, scientists have developed quite a number of methods to derive flavonoids14,15. However, chemical synthesis of these complicated molecules possesses a variety of intrinsic disadvantages16. It requires not only toxic reagents and extreme reaction conditions, but also many steps to produce a target flavonoid compound14,17. Moreover, another important challenge in this strategy is the chiral synthesis of active flavonoid molecules. Therefore, it is not an ideal strategy to produce flavonoids at a commercial scale via chemical synthesis16,17.
Recently, scientists have developed a promising alternative strategy to produce these complicated natural compounds by engineering microbes with a pathway for flavonoid biosynthesis18,19,20,21,22, which has been successfully deciphered in plants23. For example, Duan et al. introduced a biosynthetic pathway into the budding yeast Saccharomyces cerevisiae to produce kaempferol (KMF)24. Malla et al. produced astragalin, a glycosylated flavonol, by introducingflavanone 3-hydroxylase (f3h), flavonol synthase (fls1), and UDP-glucose:flavonoid 3-O-glucosyltransferase UGT78K1 genes into Escherichia coliBL21(DE3)17. Even though there are quite a few paradigms, not all genetically engineered microbes produce the products of interest due to the complexity of a cellular platform, the incompatibility between artificially synthesized genetic elements and hosts, the inhibitory effect of target products against host cells, and the instability of an engineered cellular system itself16.
Another promising alternative strategy for flavonoid production is to establish a multienzymatic cascade in vitro. Cheng et al. have reported that enterocin polyketides can be successfully synthesized by assembling a complete enzymatic pathway in one pot25. This cell-free synthetic strategy circumvents the restrictions of a microbial production factory and thus is feasible for producing some flavonoids in large quantity16.
Recently, we have successfully developed a bienzyme synthetic system to convert naringenin (NRN) into KMF in one pot16. Here, we describe this system in great details and the methods involved in analyzing the products. We also present two examples that use this system to produce KMF from NRN and quercetin (QRC) from eriodictyol (ERD). In addition, we discuss crucial steps of this method and future research directions in the biosynthesis of flavonoids.
1. Isolate total RNA from plant tissues26,27
2. Synthesize complementary DNA (cDNA)28
Reagents | Volume |
dNTP Mix, 2.5mM each | 4.0 μL |
Primer Mix | 2.0 μL |
RNA Template | 1.0 μg |
Reverse Transcriptase Buffer, 5× | 4.0 μL |
Reverse Transcriptase, 200 U/μL | 1.0 μL |
RNase-Free H2O | up to 20.0 μL |
Table 1: Reverse transcription of total RNA into cDNA
3. Construct recombinant plasmids29
Sequence, 5' → 3' | Purpose |
AAGGATCCATGGCTCCAGGAACTTTGACT | Forward primer for PCR amplification of Atf3h gene from Arabidopsis thaliana. BamHI site is italicized and attached for cloning into pET32a(+). |
AAGAATTCCTAAGCGAAGATTTGGTCGA | Reverse primer for PCR amplification of Atf3h gene from A. thaliana. EcoRI site is italicized and attached for cloning into pET32a(+). |
AAGGATCCATGGAGGTCGAAAGAGTCCA | Forward primer for PCR amplification of Atfls1 gene from A. thaliana. BamHI site is italicized and attached for cloning into pET32a(+). |
AAGAATTCTCAATCCAGAGGAAGTTTAT | Reverse primer for PCR amplification of Atfls1 gene from A. thaliana. EcoRI site is italicized and attached for cloning into pET32a(+). |
Table 2: Oligonucleotide primers used in the current study
Reagents | Volume |
Pfu Master Mix, 2× | 50.0 μL |
Forward Primer, 10 μM | 4.0 μL |
Reverse Primer, 10 μM | 4.0 μL |
cDNA | 2.0 μL |
H2O | 40.0 μL |
Table 3: Setting up of a PCR reaction system
Reagents | Volume |
DNA Fragment/Vector | 3.0 μg |
BamHI | 1.0 μL |
EcoRI | 1.0 μL |
Cutsmart Buffer, 10× | 5.0 μL |
H2O | up to 50.0 μL |
Table 4: Double digestion of a DNA fragment/vector
Reagents | Volume |
Insert | X μL (0.09 pmol) |
Vector | Y μL (0.03 pmol) |
Ligation Buffer, 10× | 1.0 μL |
T4 DNA Ligase, 400 U/μL | 1.0 μL |
H2O | up to 10.0 μL |
Table 5: Ligation of a gene fragment into a linearized vector
4. Express recombinant enzyme proteins30
5. Purify the recombinant enzyme proteins31
6. Produce a flavonol from a flavanone in an in vitro bienzyme synthetic system16
Reagents | Volume |
2× Synthetic Buffer without ferrous sulfate | 50.0 μL |
25 mM flavonol | 2.0 μL |
2 mM ferrous sulfate | 0.5 μL |
1 mg/mL AtF3H | 2.5 μL |
1 mg/mL AtFLS1 | 2.5 μL |
25 mM flavanone | 2.0 μL |
H2O | up to 100.0 μL |
Table 6: The synthetic system used in this protocol.
7. Analyze the reaction products
F3H and FLS1 are two important key enzymes in the conversion of a flavanone into a flavonol in plants as shown in Figure 1. To develop an in vitro biosynthetic system for producing a flavonol from a flavanone, Atf3h (GenBank accession no.NM_114983.3) and Atfls1 (GenBank accession no. NM_120951.3) genes were cloned from the seedlings of 4-week-old A. thaliana into a prokaryotic expression vector pET-32a(+). The recombinant plasmids were transformed into E. coli BL21(DE3) and the fusion proteins were expressed after IPTG induction, followed by purification using Ni-IDA agarose resins. As shown in Figure 2, the purified fusion proteins showed a high purity of over 95% on a 10% SDS-PAGE gel, which were pure enough for the establishment of an in vitro bienzymatic cascade.
Figure 1: Schematic representation for the biosynthesis of a flavonol from a flavanonein vitro.F3H, flavanone 3-hydroxylase; FLS1, flavonol synthase 1. Please click here to view a larger version of this figure.
Figure 2: Purification of recombinant AtF3H and AtFLS1 proteins. The Atf3h and Atfls1 genes were cloned from 4-week-old seedlings of Arabidopsis thaliana into a prokaryotic expression vector pET-32a(+) and expressed in Escherichia coli BL21(DE3). The recombinant proteins were purified through an affinity chromatography column filled with Ni-IDA agarose resins. The purity was determined on a 10% SDS-PAGE gel. M, protein markers; 1, recombinant AtF3H protein; 2, recombinant AtFLS1 protein. Please click here to view a larger version of this figure.
To establish a bienzymatic cascade using the purified recombinant proteins, a synthetic system was prepared as shown in Table 6. To determine whether this system can be used for the conversion of a flavanone into a flavonol, NRN was added into the system, and the biosynthesis of KMF was detected by TLC and HPLC/LC/MS analyses. As shown in Figure 3A, there were two new spots emerged on a polyamide TLC plate. One spot showed a migration distance similar to that of dihydrokaempferol (DHK), and the other similar to that of KMF. Further analysis by HPLC and LC/MS demonstrated that the new chemicals showed a retention time of 11.91 min and 20.16 min, respectively (Figure 3B) and a quasi-molecular ion peak [M−H]− at m/z 287.0500 and 285.0500, respectively (Figure 3C), which were identical to those of DHK and KMF, respectively. The data indicate that KMF was produced from NRN in this system and the yield was as high as 34.94 mg/L.
Figure 3: Synthesis of KMF from NRN in a bienzymatic cascade. (A) Analysis of the one-pot reaction products by polyamide TLC. 1, NRN standard; 2, DHK standard; 3, KMF standard; 4, reaction mixture. (B) HPLC analysis profiles of the reaction products. NRN, DHK, and KMF showed a retention time of 18.74 min, 11.91 min, and 20.16 min, respectively. (C) MS analysis profiles of the flavonoid compounds in the reaction mixtures. Please click here to view a larger version of this figure.
To further determine whether this in vitro system can be used for the conversion of other flavanones into their corresponding flavonols, eriodictyol (ERD) was added into the system to determine whether ERD can be converted into quercetin (QRC). As shown in Figure 4A, two new spots on a polyamide TLC plate displayed a migration distance similar to that of dihydroquercetin (DHQ) and QRC, respectively. HPLC and LC/MS analyses demonstrated that these new chemicals revealed a retention time of 10.03 min and 16.23 min, respectively (Figure 4B) and a quasi-molecular ion peak [M−H]− at m/z 303.1000 and 301.1000, respectively (Figure 4C), which exactly corresponded to those of DHQ and QRC, respectively. The data indicate that this system can convert ERD into QRC and the yield was 25.55 mg/L.
Figure 4: Production of QRC from ERD in a bienzyme synthetic system. (A) Analysis of the reaction products by polyamide TLC. 1, ERD standard; 2, DHQ standard; 3, QRC standard; 4, reaction mixture. (B) HPLC analysis profiles of the reaction products. ERD, DHQ, and QRC displayed a retention time of 15.45 min, 10.03 min, and 16.23 min, respectively. (C) MS analysis profiles of the compounds in the reaction mixtures. Please click here to view a larger version of this figure.
Quite a number of studies are focused on the derivation of flavonols due to their potential application in health care and food industry. However, traditional plant extraction using organic solvents and chemical synthesis possess intrinsic disadvantages, which restrict their use in the production of flavonols. Here, we report a detailed method for producing a flavonol from a flavanone in one pot by establishing an in vitro bienzymatic cascade. The critical steps in this protocol are: 1) obtaining pure recombinant enzymes with high activities and 2) establishing a one-pot bienzymatic reaction cascade. Generally speaking, the expression of plant-derived genes in bacteria prefers to form inclusion body, which will lead to the loss of enzyme activity. As we know, some peptides, such as TrxA and SUMO, help to enhance the expression and solubility of recombinant proteins expressed in bacteria16. Therefore, it will be helpful to clone the target genes into the plasmids containing these expression tags, such as pET-32a(+) and pET SUMO (Step 3.2.3). It is well known that IPTG concentration and induction temperature are another two crucial parameters affecting the solubility of prokaryotically expressed proteins16. To further decrease the formation of inclusion body, IPTG concentration and induction temperature should be optimized. The optimum IPTG concentration and induction temperature mainly depends on the type of plasmids and the bacteria strains. In this protocol, the IPTG concentration and induction temperature are optimized at 0.2 mM and 20 – 22 °C, respectively (Step 4.2.3). In addition, temperature and glycerol are two important parameters for maintaining the stability and activity when purifying and storing the recombinant enzymes. In this protocol, it is crucial to purify the recombinant proteins at 4 °C (Steps 5.5 – 5.12), add 10% glycerol into the solution of purified enzymes (Step 5.13), and immediately aliquot and store the solution at -80 °C (Step 5.13). In establishment of a one-pot reaction cascade, pH and temperature are two vital parameters. It is obvious that too high pH is harmful for the conversion because the ferrous ions (Fe2+), a necessary component for the enzyme activity of recombinant F3H and FLS116,32,33, are precipitated by forming a slurry of ferrous hydroxide under such a condition. Even though a relatively higher temperature facilitates the progress of an enzyme-catalyzed reaction, too high temperature will inactivate the enzyme. Therefore, it is critical for the conversion to stabilize the pH and reaction temperature. Our previous publication sets the optimum pH and temperature at 7.2 and 40 °C, respectively (Step 6)16.
This protocol could be conveniently modified to biosynthesize a number of flavonols from various flavanones using different substrates. In this protocol, two examples are provided. As shown in Figure 3, when adding NRN as a substrate into this system, new chemicals were produced. TLC and HPLC/LC/MS analyses indicate that the new chemicals were DHK and KMF, and the NRN was converted into the KMF in this system. To further strengthen confidence in the results, spectral characterization of 1H NMR (hydrogen-1 nuclear magnetic resonance), 13C NMR (carbon-13 nuclear magnetic resonance), NOESY (Nuclear Overhauser Effect SpectroscopY), XRD (X-ray powder diffraction), CHN analyzer and the like may be required to attest the presence of chemicals in a new entity. Similarly, ERD could be successfully converted into QRC in this bienzymatic cascade (Figure 4).
There is an important limitation for this method. According to the known biosynthetic pathway of flavonoids, a flavonol can be produced by this system from an aromatic amino acid or its downstream derivatives. For example, KMF can be produced from p-coumaric acid by a series of key enzymes, including 4-coumaroyl:CoA-ligase (4CL), chalcone synthase (CHS), chalcone isomerase (CHI), F3H and FLS23. Similarly, QRC can be produced from caffeic acid using the same panel of key enzymes (unpublished data). However, coenzyme A (CoA), ATP, and manonyl-CoA need to be included in the system to convert p-coumaric acid into KMF, which will greatly increase the production cost. Therefore, this system is usually restricted to convert a flavanone into a dihydroflavonol or a flavonol. In addition, complete conversion of starting materials is another challenge. To further improve the efficiency of this system, future research should be focused on screening key enzymes with high activities from other plants, mutation of genes encoding key enzymes, immobilization of the highly active enzymes to inert carriers, and development of a better buffer system.
This one-pot bienzyme synthetic system possesses obvious intrinsic advantages over other approaches to produce a flavonol, such as chemical synthesis, microbial cell factory, and plant extraction using organic solvents16. Firstly, the reaction time is very short and needs only 40 min, so this production system is labor- and time-saving. Secondly, there is no complex physiological regulation in this system as occurred in the microbial cell factory and moreover, all components are clear. Therefore, it is easy to control the reaction accurately and thus convenient to make further optimization in the future. Thirdly, since this reaction system contains only simple chemicals and purified recombinant enzymes and only generates one major intermediate as shown in Figure 3 and Figure 4, it is expected that it is easier to purify the target molecules generated in this system than those from cell factories and plants. Fourthly, the major components of the system are common and cheap chemicals and prokaryotically expressed recombinant enzymes, so it is highly cost-effective for this method to derive desired flavonoids. Fifthly, due to the simplicity of the components of this system, it is easy to scale up for mass production of target flavonoids, indicating a huge industrialization potential. In addition, this system provides a guide for the economical production of other secondary metabolites.
The authors have nothing to disclose.
This work was financially supported by Yangzhou University Specially-Appointed Professor Start-up Funds, Jiangsu Specially-Appointed Professor Start-up Funds, Six Talent Peaks Project in Jiangsu Province (Grant No. 2014-SWYY-016), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Veterinary Medicine). We thank the Testing Center of Yangzhou University for HPLC and MS analyses of flavonoids.
2× Pfu MasterMix | Beijing CoWin Biotech Co., Ltd | CW0717A | PCR amplification of genes with high fidelity |
Agilent 1200 Series RRLC system with an Agilent 6460 Triple Quadrupole LC/MS system | Agilent Technologies, Inc | N/A | an equipment for analysis of flavonoids by HPLC/MS |
Agilent MassHunter Workstation (version B.03.01) | Agilent Technologies, Inc | N/A | a software for collection of the data from the Agilent 1200 Series RRLC system with an Agilent 6460 Triple Quadrupole LC/MS system |
dihydrokaempferol | Sigma-Aldrich Co. LLC | 91216 | intermediate product for producing kaempferol from naringenin |
dihydroquercetin | Sichuan Provincial Standard Substance Center for Chinese Herbal Medicine | PCS0371 | intermediate product for producing quercetin from eriodictyol |
DNA Clean-up Kit | Beijing CoWin Biotech Co., Ltd | CW2301 | purification of PCR-amplified or gel-purified DNA |
eriodictyol | Shanghai Yuan Ye Biotechnology Co., Ltd. | B21160 | substrate for producing quercetin |
Escherichia coli BL21(DE3) | Beijing CoWin Biotech Co., Ltd | CW0809 | bacteria strain for expressing target genes |
Escherichia coli DH5α | Beijing CoWin Biotech Co., Ltd | CW0808 | bacteria strain for plasmid proliferation |
FreeZone 1 Liter Benchtop Freeze-Dry System | Labconco Corporation | 7740020 | an equipment for freeze-drying of flavonoids dissolved in organic solvent |
Gel Extraction Kit | Beijing CoWin Biotech Co., Ltd | CW2302 | purification of a DNA band from an agarose gel |
Gel Imaging System | Shanghai Tanon Science & Technology Co. Ltd. | Tanon- 2500 |
an equipment for visualization of DNA band on an agarose gel or flavonoid spot on a polyamide TLC plate |
GenElute Plasmid Miniprep Kit | Sigma-Aldrich Co. LLC | PLN350-1KT | minipreparation of plasmids |
kaempferol | Sigma-Aldrich Co. LLC | 60010 | final reaction product and standard substance |
MassHunter Quanlitative Analysis (version B.01.04) | Agilent Technologies, Inc | N/A | a software for analysis of HPLC/LC/MS data |
NanoDrop Microvolume UV-Vis Spectrophotometer | Thermo Fisher Scientific | ND-8000-GL | an equipment for determination of DNA/RNA concentration |
naringenin | Sigma-Aldrich Co. LLC | N5893 | substrate for producing kaempferol |
Ni-IDA Agarose Resin | Beijing CoWin Biotech Co., Ltd | CW0010 | purification of His-tagged fusion proteins |
pET-32a(+) | Novagen | 69015-3 | plasmid for cloning and expressing target genes |
plasmid sequencing | GENEWIZ Suzhou | N/A | sequencing of recombinant plasmids |
primer synthesis | GENEWIZ Suzhou | N/A | synthesis of PCR primers |
quercetin | Shanghai Aladdin Biochemical Technology Co.,Ltd. | Q111273 | final reaction product and standard substance |
SuperRT cDNA Synthesis Kit | Beijing CoWin Biotech Co., Ltd | CW0741 | synthesis of the first strand of cDNA from total RNA |
T4 DNA Ligase | Thermo Fisher Scientific | EL0016 | ligation of an insert into a linearized vector DNA |
Trizol | Thermo Fisher Scientific | 15596018 | isolation of total RNA |
Vector NTI Advance | Thermo Fisher Scientific | 12605099 | a software for PCR primer design and DNA sequence analysis |
Xcalibur v2.0.7 | Thermo Fisher Scientific | N/A | a software for analysis of HPLC data |